Hims & Hers Health, Inc. (HIMS) Revenue CAGR:32.83%(TTM)
The revenue cagr for Hims & Hers Health, Inc. (HIMS) is +32.83% over the latest trailing 12-month period. Revenue CAGR uses precomputed financial statement history.
The revenue CAGR for Hims & Hers Health, Inc. (HIMS) stock is 32.83% over the past 12 months. The 3 year CAGR is 56.64% and the 5 year CAGR is 69.19%. Revenue CAGR measures how Hims & Hers Health, Inc.'s top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
HIMS Revenue CAGR Chart
Hims & Hers Health, Inc. (HIMS)
HIMS Quarterly Revenue Growth (YoY)
Revenue growth vs the same quarter one year earlier, last 20 quarters.
HIMS Revenue CAGR History
| Year | Start Revenue | End Revenue | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $1.48B | $2.35B | +$871.12M | +59.00% | +59.00% |
| 2024 | $872.00M | $1.48B | +$604.51M | +69.33% | +69.32% |
| 2023 | $526.92M | $872.00M | +$345.08M | +65.49% | +65.49% |
| 2022 | $271.88M | $526.92M | +$255.04M | +93.81% | +93.81% |
| 2021 | $148.76M | $271.88M | +$123.12M | +82.77% | +82.77% |
| 2020 | $82.56M | $148.76M | +$66.20M | +80.18% | +80.18% |
Quarterly Revenue: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $608.10M | -1.6% | +3.8% |
| Q4 2025 | $617.82M | +3.1% | +28.4% |
| Q3 2025 | $598.98M | +9.9% | +49.2% |
| Q2 2025 | $544.83M | -7.0% | +72.6% |
| Q1 2025 | $586.01M | +21.8% | +110.7% |
| Q4 2024 | $481.14M | +19.8% | +95.1% |
| Q3 2024 | $401.56M | +27.2% | +77.1% |
| Q2 2024 | $315.65M | +13.5% | +51.8% |
| Q1 2024 | $278.17M | +12.8% | +45.8% |
| Q4 2023 | $246.62M | +8.8% | +47.5% |
| Q3 2023 | $226.70M | +9.0% | +56.5% |
| Q2 2023 | $207.91M | +9.0% | +83.1% |
| Q1 2023 | $190.77M | +14.1% | +88.3% |
| Q4 2022 | $167.20M | +15.4% | +97.4% |
| Q3 2022 | $144.84M | +27.5% | +95.3% |
| Q2 2022 | $113.56M | +12.1% | +87.1% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum